Proskauer has advised Dimension. Dimension, a venture capital firm focused on the intersection of biotechnology and artificial intelligence, has announced the closing of its latest fund,...
Dimension Closes $800 Million Fund to Expand Science and Compute Investments
Flexstone Partners to Acquire Glouston Capital Partners
Proskauer has advised Glouston Capital Partners. Flexstone Partners, a global private markets investment manager and affiliate of Natixis Investment Managers, has reached a definitive agreement to...
Glouston Capital Partners’ Formation of Seventh Secondaries Fund
Proskauer advised Glouston Capital Partners on the deal. Glouston Capital Partners (“GCP”), a Boston-based independent private equity manager, announced the launch of its seventh flagship secondaries...
ARCH Venture Partners’ $3 Billion Closing of Venture Fund XIII
Proskauer advised ARCH Venture Partners on the transaction. ARCH Venture Partners (“ARCH”) announced the closing of ARCH Venture Fund XIII. The fund closed with more than...
Flagship Pioneering’s $3.6 Billion Fundraising
Proskauer represented Flagship Pioneering in the transaction. Flagship Pioneering (“Flagship”), a bioplatform innovation company, raised an additional $3.6 billion of capital to fund the creation and...
ARCH Venture Fund XII’s $2.975 Billion Fundraising
Proskauer advised ARCH Venture Partners on the transaction. ARCH Venture Partners (“ARCH”) announced the closing of ARCH Venture Fund XII. The fund closed with $2.975 billion...
Flagship Pioneering’s $3.4 Billion Fund VII Closing
Proskauer advised Flagship Pioneering on the transaction. Flagship Pioneering, which conceives, creates, resources, and develops first-in-category bioplatform companies to transform human health and sustainability, completed the...